EUROPE SAYS
  • Europe
    • France
    • Germany
    • Netherlands
    • Belgium
    • Luxembourg
    • Switzerland
    • Austria
    • Denmark
    • Poland
    • Czech Republic
    • Slovakia
    • Slovenia
    • Croatia
  • ↓
    • Italy
    • Vatican
    • Spain
    • Portugal
  • ←
    • United Kingdom
    • Ireland
  • ↑
    • Iceland
    • Norway
    • Sweden
    • Finland
    • Estonia
    • Latvia
    • Lithuania
  • →
    • Russia
    • Belarus
    • Ukraine
    • Moldova
    • Hungary
    • Romania
    • Bulgaria
    • Greece
    • Cyprus
    • Türkiye
  • UK
  • FR
  • DE
  • IT
  • US
  • World
    • Canada
    • US
    • Japan
    • South Korea
    • Politics
    • Immigration
    • AI
    • Data
    • Environment
    • Energy
    • Nuclear
    • Crude Oil
    • Petroleum
    • Natural Gas
    • Space
    • Crypto
    • Business
    • Economy
  • Conflicts
    • NATO
    • Ukraine
    • Israel
    • Climate
    • Refugees
    • Asylum
    • Immigrant
    • Migrant

Categories

  • AI
  • Andorra
  • Asylum
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bulgaria
  • Business
  • Canada
  • Climate
  • Conflicts
  • Croatia
  • Crude Oil
  • Crypto
  • Cyprus
  • Czech Republic
  • Data
  • Denmark
  • Economy
  • Energy
  • Environment
  • Estonia
  • Europe
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Immigrant
  • Immigration
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Markets
  • Migrant
  • Moldova
  • Monaco
  • NATO
  • Natural Gas
  • Netherlands
  • New Zealand
  • News
  • Norway
  • Nuclear
  • Olympics
  • Petroleum
  • Poland
  • Politics
  • Portugal
  • Refugees
  • Romania
  • Royal Families
  • Russia
  • San Marino
  • Slovakia
  • Slovenia
  • South Korea
  • Space
  • Spain
  • Sweden
  • Switzerland
  • Türkiye
  • Ukraine
  • United Kingdom
  • United States
  • Vatican
  • World
EUROPE SAYS
  • Europe
    • France
    • Germany
    • Netherlands
    • Belgium
    • Luxembourg
    • Switzerland
    • Austria
    • Denmark
    • Poland
    • Czech Republic
    • Slovakia
    • Slovenia
    • Croatia
  • ↓
    • Italy
    • Vatican
    • Spain
    • Portugal
  • ←
    • United Kingdom
    • Ireland
  • ↑
    • Iceland
    • Norway
    • Sweden
    • Finland
    • Estonia
    • Latvia
    • Lithuania
  • →
    • Russia
    • Belarus
    • Ukraine
    • Moldova
    • Hungary
    • Romania
    • Bulgaria
    • Greece
    • Cyprus
    • Türkiye
  • UK
  • FR
  • DE
  • IT
  • US
  • World
    • Canada
    • US
    • Japan
    • South Korea
    • Politics
    • Immigration
    • AI
    • Data
    • Environment
    • Energy
    • Nuclear
    • Crude Oil
    • Petroleum
    • Natural Gas
    • Space
    • Crypto
    • Business
    • Economy
  • Conflicts
    • NATO
    • Ukraine
    • Israel
    • Climate
    • Refugees
    • Asylum
    • Immigrant
    • Migrant

Browsing Tag

AB SCIENCE

4 posts
UUnited States
Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch
Read More

AB Science announces the successful completion of a 2.55 million euros private placement

  • 04.08.2025
AB Science PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.55 MILLION PRIVATE PLACEMENT Paris,…
UUnited States
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
Read More

AB Science announces the successful completion of a EUR

  • 08.07.2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8,…
UUnited States
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
Read More

AB Science will present new data from masitinib clinical

  • 05.05.2025
PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO…
UUnited States
Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch
Read More

Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch

  • 04.03.2025
AB Science PRESS RELEASE ARTICLE FROM THE LEADING PUBLICATION LIFE SCIENCES MAGAZINE FEATURING AB SCIENCE’S MASITINIB AND ITS…
EUROPE SAYS
www.europesays.com